Iridex Corp (IRIX) Appoints Patrick Mercer as President

On May 22, 2024, the board of directors (the “Board”) of Iridex Corp (NASDAQ: IRIX) appointed Patrick Mercer as its President, effective as of such date. Mr. Mercer will continue to hold the position of Chief Operating Officer and assume the responsibilities of both roles. David I. Bruce will continue to serve in his roles as the Company’s Chief Executive Officer and as a member of the Board.

This modification in responsibilities allows Mr. Mercer to focus on the operations of the Company and Mr. Bruce to focus on pursuit of the Company’s strategic alternatives. The background and business experience of Mr. Mercer and transactions between Mr. Mercer and the Company are subject to disclosure under Item 404(a) of Regulation S-K and are disclosed in the Company’s Proxy Statement for its 2024 annual meeting of stockholders, as filed with the Securities and Exchange Commission on April 29, 2024.

You May Also Be Interested In

• Elite Pharmaceuticals launches generic Ropinirole Extended-Release Tablets
• Rhythm Pharmaceuticals RM-718 shows BMI reduction in Phase 2 trial
• Quanta Services prices $2B senior notes offering across three tranches